XML 38 R28.htm IDEA: XBRL DOCUMENT v3.25.3
Organization and Significant Accounting Policies (Details) - USD ($)
3 Months Ended 9 Months Ended
Apr. 15, 2025
Mar. 06, 2024
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
May 25, 2005
Organization and Significant Accounting Policies [Line Items]                        
Cash and cash equivalents     $ 267,625           $ 267,625   $ 626,879  
Accumulated deficit     (45,992,100)           (45,992,100)   (44,026,679)  
Working capital deficit     4,300,000           4,300,000      
Net loss     (651,482) $ (528,367) $ (785,572) $ (1,117,911) $ (1,438,130) $ (955,892) (1,965,421) $ (3,511,933)    
Cash flows from operating activities                 (3,729) $ (704,836)    
Advanced additional amount     270,000           270,000      
Borrowings from related parties     $ 1,413,340           $ 1,413,340   $ 1,144,985  
Reverse stock split   1-for-5                    
China Pharma [Member]                        
Organization and Significant Accounting Policies [Line Items]                        
Reverse stock split 1-for -10                      
Onny Investment Limited [Member]                        
Organization and Significant Accounting Policies [Line Items]                        
Ownership percentage     100.00%           100.00%      
Hainan Helpson Medical & Biotechnology Co., Ltd [Member]                        
Organization and Significant Accounting Policies [Line Items]                        
Ownership percentage     100.00%           100.00%     100.00%
Share-Based Payment Arrangement, Option [Member]                        
Organization and Significant Accounting Policies [Line Items]                        
Potentially dilutive common shares (in Shares)                 1,330 1,330